What the name refers to
A modified fragment of human growth hormone studied for metabolic effects; it is distinct from full-length somatropin.
Evidence and regulatory context
No broadly authorised human medicine is established for this entry. Published evidence may be preclinical, early-stage or sparse, and a research label is not a quality or safety certification.
Reading product records
Keep evidence from an authorised or trial formulation separate from an online vial carrying the same name. Product records should identify the exact active ingredient and form, measured peptide amount, batch, storage history and whether the document covers identity, quantity or both.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.